AF ablation with 3D mapping: our technique and results

Slides:



Advertisements
Similar presentations
Integration of Imaging: Impact on Outcome of AF Ablation Ahmed Abdelaal, MD CHU Nancy, France CAIROSTIM NOV 2008.
Advertisements

OPTN Modifications to Heart Allocation Policy Implemented July 12, 2006 Changed the allocation order for medically urgent (Status 1A and 1B) patients Policy.
Cardiac Risk In ESRD Patient
Atrial Fibrillation Ablation: My personal experience
Do You Know Your Numbers? National Governors Association Using Data, Technology, and Benefit Design to Manage State Employee and Retiree Health Programs.
AF ablation: A single operator’s experience over 3 years (2007 – 2009) Barker D, Patwala A, Damm E, Hall M, Snowdon R, Gupta D Liverpool Heart and Chest.
Catheter Ablation in the Treatment of Atrial Fibrillation
Screening and diagnosis of AF and stratifying stroke risk.
Surgical Risk Dr Chris Snowden MD FRCA Consultant Anaesthetist
AF ablation is a waste of time and money
CHANGING WORLDS The Impact of University Research.
CANCER SCREENING 2011 DELAWARE CANCER EDUCATION ALLIANCE STEPHEN S. GRUBBS, M.D. HELEN F. GRAHAM CANCER CENTER DELAWARE CANCER CONSORTIUM OCTOBER 5, 2011.
UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.
Widimsky P, Tousek P, Rokyta R, et al. Charles University Prague, CZ PRAGUE-7 Study (Hot Lines presenter)
Concomitant Atrial Fibrillation - allways Maze? - Robert JM Klautz chief department Cardiothoracic Surgery.
Hybrid AF Ablation Sequential thoracoscopic and percutaneous ablation for Lone AF Dr Guy Haywood Consultant Cardiac Electrophysiologist South West Cardiothoracic.
Long-term Efficacy and Safety of Catheter Ablation for AF: What is the Evidence? AHA QCOR Washington DC D. George Wyse MD PhD May 20, 2010.
How to do a Roof Line and Prove Block Dhiraj Gupta Liverpool Heart and Chest Hospital.
Ablation for Paroxysmal Atrial Fibrillation (APAF) Trial Presented at The American College of Cardiology Scientific Session 2006 Presented by Dr. Carlo.
INTERVENTIONAL TREATMENT OF ATRIAL FIBRILLATION St. Mary’s Hospital February – August 2007.
Clinical Title Date Jaret Tyler, MD Clinical Cardiac Electrophysiologist Assistant Professor of Medicine Ohio State’s Heart and Vascular Center Atrial.
Treating Atrial Fibrillation Richard Schilling St Bartholomew's Hospital, Queen Mary’s University of London.
Katheterablatie van atriumfibrilleren Waar staan we? Lukas Dekker.
John R Onufer MD FHRS.  Paroxysmal(that which terminates spontaneously) Persistent Sustained > 7 days, or lasting < 7 days but requires pharmacologic.
Audit of ablation procedures for AF Barts and The London.
Atrial Fibrillation Ablation Cardiology Symposium December 6, 2004 Paul R. Steiner, M.D. Cardiac Electrophysiology.
Samer Nasr, M.D. Mount Lebanon Hospital..  Lone atrial fibrillation:  Younger than 60 years old.  No clinical or echo evidence of cardiopulmonary.
Dubrava University Hospital Zagreb, Croatia DEPARTMENT OF CARDIAC SURGERY RF Ablation of Atrial Fibrillation in Valvular Heart Surgery Patients.
Late outcomes of the Cox-Maze IV procedure for atrial fibrillation Matthew C. Henn MD, Timothy S. Lancaster MD, Jacob R. Miller MD, Laurie A. Sinn RN,
THE RHYTHM IN LIFE THE SEASONS DO NOT PUSH ONE ANOTHER; NEITHER DO CLOUDS RACE THE WIND ACROSS THE SKY. ALL THINGS HAPPEN IN THEIR OWN GOOD TIME.
Basic Mechanisms of Atrial Fibrillation Relative to Ablation Osama Diab MD, Cardiology Lecturer of Cardiology, Ain Shams Universitry-Cairo Consultant Electrophysiologist,
RADIOFREQUENCY ABLATION OF FIBRILLATION: What clinicians should know. DR CARLOS LABADET Electrophysiology Sector Dr. Cosme Argerich Hospital.
Catheter Ablation of Atrial Fibrillation: Who? How? How Good? John D. Day, M.D. Director, Utah Cardiovascular Research Institute Utah Heart Clinic Arrhythmia.
AF: Catheter Ablation Isolation of the 4 pulmonary veins Linear lesions to create additional lines of block 1.
Redo afib ablation John R Onufer MD FHRS
Catheter Ablation of AF Electrogram-based Approach
Asklepios Klink St. Georg, Hamburg
Atrial Fibrillation Ablation: Who and Why ?
Catheter Ablation of Atrial Fibrillation in the Last 10 Years: Breakthroughs and Advances Dr. Feifan Ouyang Asklepios Klinik St. Georg Hamburg Sept. 19th,
A-4 Trial Presented at The Heart Rhythm Society Meeting May 2006 Presented by Dr. Pierre Jais Atrial Fibrillation Ablation vs. Antiarrhythmic Drugs Trial.
Catheter Ablation of AF Electrogram-based Approach Division of Cardiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei,
Experiences with Ultracinch and Ultrawand HIFU Techniques for Ablation Therapy M. Dalrymple-Hay FRCS FECTS PhD Consultant Cardiac Surgeon Declared Interests.
Atrial fibrillation April 2010 : 1,980,000 March 2011: 2,550,000 hits November 2014: 9,500,000 hits.
Date of download: 7/6/2016 Copyright © The American College of Cardiology. All rights reserved. From: Catheter-induced linear lesions in theleft atrium.
Catheter Ablation of Atrial Fibrillation by Roderick Tung, Eric Buch, and Kalyanam Shivkumar Circulation Volume 126(2): July 10, 2012 Copyright.
Dynamic Ranges of Contact Force During Radiofrequency Ablation
Is There a Need to Address AF in patients Undergoing Valve Surgery?
Screening and diagnosis of AF and stratifying stroke risk
Atrial fibrillation II: rationale for surgical treatment
ALFIO STUTO SEAL WHEALTH TEAM, SIRACUSA, ITALY
Edward J. Davies, MBBS, Ben Clayton, MBChB, Ian Lines, Guy A
Left atrial ablation for atrial fibrillation. A
Surgical treatment of atrial fibrillation: State of the art, 2012
Figure 1 Pulmonary vein anatomical locations
Volume 15, Issue 1, Pages (January 2018)
The State of the Art Mayo Clinic Proceedings
AF ablation with 3D mapping: our technique and results
MAGIC-AF Trial design: Patients with persistent atrial fibrillation (AF) and remaining in AF after pulmonary vein isolation alone were randomized to either.
Initial Experience of Sequential Surgical Epicardial-Catheter Endocardial Ablation for Persistent and Long-Standing Persistent Atrial Fibrillation With.
The Outcome of the Cox Maze Procedure in Patients With Previous Percutaneous Catheter Ablation to Treat Atrial Fibrillation  Niv Ad, MD, Linda Henry,
Junaid A.B. Zaman et al. JACEP 2017;3:
Shohreh Honarbakhsh et al. JACEP 2017;j.jacep
Stavros Stavrakis et al. JACEP 2015;1:1-13
Restoration of sinus rhythm and atrial transport function after the maze procedure: U lesion set versus box lesion set  Takashi Nitta, MD, PhD, Yosuke.
Atrial fibrillation II: rationale for surgical treatment
Techniques for the provocation, localization, and ablation of non–pulmonary vein triggers for atrial fibrillation  Pasquale Santangeli, MD, PhD, Francis.
Focal atrial tachycardia and atrial fibrillation from a pulmonary vein aneurysm  Konstantinos Sotiropoulos, MD, Benjamin Berte, MD, PhD, Vanessa Weberndoerfer,
Pseudo-conduction block at the mitral isthmus in a patient with epicardial impulse propagation through the vein of Marshall  Rintaro Hojo, MD, Seiji Fukamizu,
Julien Seitz et al. JACEP 2016;2:
Matthew C. Henn, MD, Christopher P. Lawrance, MD, Laurie A
Presentation transcript:

AF ablation with 3D mapping: our technique and results Dr Dhiraj Gupta MRCP MD DM Liverpool Heart and Chest Hospital Northern UK AF experts Best Practice meeting Langdale Hotel, Cumbria 5 Feb 2010

Schema Our approach to AF ablation at LHCH Our reasons for each step Our in-lab and follow-up results

Our approach in a nutshell PVAI with Wide area circumferential ablation CT image integration using CARTO Individualised lesion set prescription Aim to ablate out of AF, ideally to SR Procedure duration limit of 5 hours

CT image registration Critical part of the process 2 steps Single point Landmark registration Surface Registration with Fast Anatomical Mapping Takes 5-10 minutes

CT image segmentation

Fast Anatomical Map creation

Image Surface registration

Why the individualised approach? Heterogeneity amongst AF population Trigger removal vs Substrate Modification Aim to achieve high single procedure success rates Incremental risk with multiple procedures That’s what the patient wants That’s what the health economists want!

Patient selection criteria Patients not offered Catheter ablation if Very long standing Persistent AF (>3 years) Very large LA (>5.5 cm) Morbid Obesity (BMI >40), Sleep Apnea Significant RA dilatation (>LA) Patients not offered first redo at least for 6 months Not offered Second redo if still in PsAF

Not all AF patients are the same True PAF Short lived episodes, short history, normal sized LA Sustained PAF: 2 or more of the following AF episodes>24 hours, History of AF > 5 years, LA size >4.5 cm, Age >65 years, Documented flutter, High AF burden (most days) Persistent AF Long standing Persistent AF (>12 months)

Minimum RF Lesion set True PAF PVAI using WACA Sustained PAF + LA roof line + RA flutter line Persistent AF + LA floor line + Mitral isthmus line Long standing Persistent AF + Epicardial CS ablation+ CAFÉ ablation

Paroxysmal PAF

Sustained PAF

Persistent AF

Long standing Persistent AF

Surgical Maze for ‘Permanent AF’ Still the Gold standard in terms of results 96% free of AF at 5 years* * SM Prasad et al, J Thorac Cardiovasc Surg 2003; 126: 1822-27

Results with ‘Catheter Maze’ N Redo AAD therapy Results Complications Haissaguerre JCE 2005 60 1/2 Stopped at ablation 95% at 11 months 2 Tamponades Oral NEJM 2006 77 1/3 Amio 6/52 pre & 3/12 post 77% at 1 year Postch Circ 2008 88 81% at 20 months 1 TIA Lo JCE 2009 87 1/4 AAD for 2/12 post 79% at 21 months 1 Tamponade

Why CT image integration? Forewarned is forearmed: PV anatomical variations Common Left Pulmonary Vein Additional pulmonary vein(s) Important anatomical information thickness of the LAA ridge, intervenous carina extent of the PV antra length of the mitral isthmus

Why CT image integration? Dramatically reduces procedural fluoro times: <10 minutes for PAF cases 10-20 minutes for PsAF cases Decreases fatigue Removes ‘the fear of the unknown’….. Demystifies AF ablation for the nurses/ radiographers!

Why CARTO rather than ESI? Unmatched catheter stability no catheter ‘dive’ with onset of RF delivery Allows linear lesions No need for stable intracardiac reference Ability to perform activation mapping if needed Great CT image integration software

Advances with CARTO-3 Hybrid of impedance and magnetic catheter location Ability to see all catheters Ability to create fast anatomical maps Makes CT image integration easier More streamlined patient set-up

Why WACA? PV ostial/ antral triggers Substrate modification by Atrial debulking Less risk of PV stenosis Quicker than segmental PVI Easy to anchor linear lesions on either side ‘Et tu, Bordeaux?!’

Why our RF settings? Continuous RF: 35 W, 50°C, 10 ml/ min flow Quicker signal obliteration than 30/25 W Short procedure time (20-30’ per WACA) Prevents peri-lesion edema (?  reconnection risk) RF controlled by Foot pedal Frees up a cardiac physiologist Imposes discipline on use of X-ray pedal!

131 consecutive pts. between Jan 08-July 09 Our results 131 consecutive pts. between Jan 08-July 09

Individualised ablation strategy True PAF (n=45) PVAI using WACA Sustained PAF (n=31) + LA roof line+ RA flutter line Ps AF (n=22) + LA floor line+ Mitral isthmus line Long standing Ps AF (n=33) + Epicardial CS ablation+ CAFÉ ablation

In-lab results All patients received prescribed minimum lesion set Mean Procedure time 173 min (98-300) Fluoroscopy times Mean 26.5 min (13-58) (as pre-CARTO 3 era) Now with CARTO-3 (n=36): Mean 14 min (6-21) Complications 1 tamponade (PVI group), 1 AV fistula

Our follow-up strategy Antiarrhythmic drug therapy for 2-3 months Early post-op arrhythmias DC CV if sustained and poorly tolerated (n=1) No redo ablation procedure for at least 6 months Mean follow up 11.3 months (6-24)

Our Clinical Results Definition of Procedural Success: No symptoms beyond 3 months, AND Absence of AF/AT on 24 hour Holter at 6 mo Single procedure success rates at 6 months PAF 84% PsAF 86% Sustained PAF 77% (p=0.05) Long standing PsAF 64% (p<0.001)

Conclusions Single procedure success should be the goal Most patients need substrate modification in addition to trigger removal This needs application of linear lesions 3D mapping guided ablation the gold standard

Acknowledgements to Dr Richard Schilling, my mentor and guide Thank You www.heartrhythmspecialist.co.uk